Agilent Technologies, Inc.
- A
- NYSE
- Medical - Diagnostics & Research
- Analytical Instruments
- Life Sciences Tools
- Diagnostics
$169.89
Today −1.78%Quote Oct 19, 2026, 07:59 PM UTC
+10.64%over the last month
Max drawdown −4.9%From 1-month high −1.5%3 months +32.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Agilent Technologies
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation.
Where the money comes from
Q3 2026 revenue $1.88B
- Agilent CrossLab$786.0M41.9%
- Life Sciences and Applied Markets$746.0M39.7%
- Applied Markets$346.0M18.4%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Employees
18,200
Dividend date
Oct 28, 2026
Market value
$47.90B
Quote Oct 19
Floor
$163.78
3.6% below price
Resistance
$170.08
0.1% above price
Price vs analyst targets
41 analysts
Lowest target
$150.00Highest target
$195.00
$150.00Highest target
$195.00
- Price $169.89
- Average target $173.08
- Analysts' target range
Analysts' average target sits about 2% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about APro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free